Sanofi completes acquisitions in Q2

Sunday 1 August 2021
Country

France

Sanofi SA completed three acquisitions in the second quarter, signalling a new direction for research and development and potentially lifting the company’s dependence on sales of the immunology drug Dupixent.

Read in full with a subscription

Learn more about subscribing to MedNous.

Subscribe